{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:34:17Z","timestamp":1791250457503,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,8,16]],"date-time":"2013-08-16T00:00:00Z","timestamp":1376611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00277-013-1860-8","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T18:00:31Z","timestamp":1376589631000},"page":"233-242","source":"Crossref","is-referenced-by-count":17,"title":["Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC"],"prefix":"10.1007","volume":"93","author":[{"given":"Cyrille","family":"Touzeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Leux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Bouabdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Delarue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krimo","family":"Bouabdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Cacheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Cartron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Compain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Gyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Morschhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Casasnovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Pierre","family":"Moles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Michallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Gressin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sirvent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Hermine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Mohty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Milpied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Le Gouill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,16]]},"reference":[{"key":"1860_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","volume":"142","author":"P Jares","year":"2008","unstructured":"Jares P, Campo E (2008) Advances in the understanding of mantle cell lymphoma. Br J Haematol 142:149\u2013165. doi: 10.1111\/j.1365-2141.2008.07124.x","journal-title":"Br J Haematol"},{"key":"1860_CR2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2010-04-189977","volume":"117","author":"P P\u00e9rez-Gal\u00e1n","year":"2011","unstructured":"P\u00e9rez-Gal\u00e1n P, Dreyling M, Wiestner A (2011) Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 117:26\u201338. doi: 10.1182\/blood-2010-04-189977","journal-title":"Blood"},{"key":"1860_CR3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/cncr.23608","volume":"113","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, Wang H, Fang W et al (2008) Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004. Cancer 113:791\u2013798. doi: 10.1002\/cncr.23608","journal-title":"Cancer"},{"key":"1860_CR4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.seminhematol.2011.06.002","volume":"48","author":"S Harel","year":"2011","unstructured":"Harel S, Delarue R, Ribrag V et al (2011) Treatment of younger patients with mantle cell lymphoma. Semin Hematol 48:194\u2013207. doi: 10.1053\/j.seminhematol.2011.06.002","journal-title":"Semin Hematol"},{"key":"1860_CR5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.seminhematol.2011.03.008","volume":"48","author":"HC Kluin-Nelemans","year":"2011","unstructured":"Kluin-Nelemans HC, Doorduijn JK (2011) Treatment of elderly patients with mantle cell lymphoma. Semin Hematol 48:208\u2013213. doi: 10.1053\/j.seminhematol.2011.03.008","journal-title":"Semin Hematol"},{"key":"1860_CR6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1200\/JCO.2008.16.8435","volume":"27","author":"A Herrmann","year":"2009","unstructured":"Herrmann A, Hoster E, Zwingers T et al (2009) Improvement of overall survival in advanced stage mantle cell lymphoma. J Clin Oncol 27:511\u2013518. doi: 10.1200\/JCO.2008.16.8435","journal-title":"J Clin Oncol"},{"key":"1860_CR7","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1182\/blood-2004-10-3883","volume":"105","author":"M Dreyling","year":"2005","unstructured":"Dreyling M, Lenz G, Hoster E et al (2005) Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the European MCL Network. Blood 105:2677\u20132684. doi: 10.1182\/blood-2004-10-3883","journal-title":"Blood"},{"key":"1860_CR8","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1200\/JCO.2009.22.2554","volume":"27","author":"LE Damon","year":"2009","unstructured":"Damon LE, Johnson JL, Niedzwiecki D et al (2009) Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle cell lymphoma: CALGB 59909. J Clin Oncol 27:6101\u20136108. doi: 10.1200\/JCO.2009.22.2554","journal-title":"J Clin Oncol"},{"key":"1860_CR9","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","volume":"112","author":"CH Geisler","year":"2008","unstructured":"Geisler CH, Kolstad A, Laurell A et al (2008) Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood 112:2687\u20132693. doi: 10.1182\/blood-2008-03-147025","journal-title":"Blood"},{"key":"1860_CR10","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1200\/JCO.1998.16.12.3803","volume":"16","author":"IF Khouri","year":"1998","unstructured":"Khouri IF, Romaguera J, Kantarjian H et al (1998) Hyper-CVAD and high-dose methotrexate\/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma. J Clin Oncol 16:3803\u20133809","journal-title":"J Clin Oncol"},{"key":"1860_CR11","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/cncr.11838","volume":"98","author":"IF Khouri","year":"2003","unstructured":"Khouri IF, Saliba RM, Okoroji G-J et al (2003) Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score. Cancer 98:2630\u20132635. doi: 10.1002\/cncr.11838","journal-title":"Cancer"},{"key":"1860_CR12","first-page":"1275","volume":"89","author":"F Lefr\u00e8re","year":"2004","unstructured":"Lefr\u00e8re F, Delmer A, Levy V et al (2004) Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study. Haematologica 89:1275\u20131276","journal-title":"Haematologica"},{"key":"1860_CR13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/cncr.21313","volume":"104","author":"C Thieblemont","year":"2005","unstructured":"Thieblemont C, Antal D, Lacotte-Thierry L et al (2005) Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma. Cancer 104:1434\u20131441. doi: 10.1002\/cncr.21313","journal-title":"Cancer"},{"key":"1860_CR14","first-page":"1580","volume":"90","author":"S Vigouroux","year":"2005","unstructured":"Vigouroux S, Gaillard F, Moreau P et al (2005) High-dose therapy with autologous stem cell transplantation in first response in mantle cell lymphoma. Haematologica 90:1580\u20131582","journal-title":"Haematologica"},{"key":"1860_CR15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1182\/blood-2002-08-2476","volume":"102","author":"AM Gianni","year":"2003","unstructured":"Gianni AM, Magni M, Martelli M et al (2003) Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen). Blood 102:749\u2013755. doi: 10.1182\/blood-2002-08-2476","journal-title":"Blood"},{"key":"1860_CR16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","unstructured":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987\u2013994. doi: 10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"key":"1860_CR17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W et al (2008) A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood 111:558\u2013565. doi: 10.1182\/blood-2007-06-095331","journal-title":"Blood"},{"key":"1860_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/TP.0b013e318256dcba","volume":"94","author":"P Peterlin","year":"2012","unstructured":"Peterlin P, Leux C, Gastinne T et al (2012) Is ASCT with TBI superior to ASCT without TBI in mantle cell lymphoma patients? Transplantation 94:295\u2013301. doi: 10.1097\/TP.0b013e318256dcba","journal-title":"Transplantation"},{"key":"1860_CR19","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17:1244","journal-title":"J Clin Oncol"},{"key":"1860_CR20","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1200\/JCO.2010.33.7055","volume":"29","author":"LE Budde","year":"2011","unstructured":"Budde LE, Guthrie KA, Till BG et al (2011) Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation. J Clin Oncol 29:3023\u20133029. doi: 10.1200\/JCO.2010.33.7055","journal-title":"J Clin Oncol"},{"key":"1860_CR21","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1200\/JCO.2005.08.133","volume":"23","author":"G Lenz","year":"2005","unstructured":"Lenz G, Dreyling M, Hoster E et al (2005) Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J Clin Oncol 23:1984\u20131992. doi: 10.1200\/JCO.2005.08.133","journal-title":"J Clin Oncol"},{"key":"1860_CR22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/djk152","volume":"99","author":"H Schulz","year":"2007","unstructured":"Schulz H, Bohlius JF, Trelle S et al (2007) Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis. J Natl Cancer Inst 99:706\u2013714. doi: 10.1093\/jnci\/djk152","journal-title":"J Natl Cancer Inst"},{"key":"1860_CR23","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2011-04-348367","volume":"118","author":"R Griffiths","year":"2011","unstructured":"Griffiths R, Mikhael J, Gleeson M et al (2011) Addition of rituximab to chemotherapy alone as first-line therapy improves overall survival in elderly patients with mantle cell lymphoma. Blood 118:4808\u20134816. doi: 10.1182\/blood-2011-04-348367","journal-title":"Blood"},{"key":"1860_CR24","first-page":"151","volume":"120","author":"O Hermine","year":"2012","unstructured":"Hermine O, Hoster E, Walewski J et al (2012) Alternating courses of 3x CHOP and 3x DHAP plus rituximab followed by a high dose ARA-C containing myeloablative regimen and autologous stem cell transplantation (ASCT) increases overall survival when compared to 6 courses of CHOP plus rituximab followed by myeloablative radiochemotherapy and ASCT in mantle cell lymphoma: final analysis of the MCL younger trial of the European mantle cell lymphoma network (MCL net). ASH Annu Meet Abstr 120:151","journal-title":"ASH Annu Meet Abstr"},{"key":"1860_CR25","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","volume":"115","author":"C Pott","year":"2010","unstructured":"Pott C, Hoster E, Delfau-Larue M-H et al (2010) Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. Blood 115:3215\u20133223. doi: 10.1182\/blood-2009-06-230250","journal-title":"Blood"},{"key":"1860_CR26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3324\/haematol.2011.050203","volume":"97","author":"H Liu","year":"2012","unstructured":"Liu H, Johnson JL, Koval G et al (2012) Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909. Haematologica 97:579\u2013585. doi: 10.3324\/haematol.2011.050203","journal-title":"Haematologica"},{"key":"1860_CR27","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood-2005-07-2845","volume":"107","author":"C Pott","year":"2006","unstructured":"Pott C, Schrader C, Gesk S et al (2006) Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. Blood 107:2271\u20132278. doi: 10.1182\/blood-2005-07-2845","journal-title":"Blood"},{"key":"1860_CR28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0140-6736(10)62175-7","volume":"377","author":"G Salles","year":"2011","unstructured":"Salles G, Seymour JF, Offner F et al (2011) Rituximab maintenance for 2\u00a0years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial. Lancet 377:42\u201351. doi: 10.1016\/S0140-6736(10)62175-7","journal-title":"Lancet"},{"key":"1860_CR29","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2006-05-021113","volume":"108","author":"MHJ Oers Van","year":"2006","unstructured":"Van Oers MHJ, Klasa R, Marcus RE et al (2006) Rituximab maintenance improves clinical outcome of relapsed\/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial. Blood 108:3295\u20133301. doi: 10.1182\/blood-2006-05-021113","journal-title":"Blood"},{"key":"1860_CR30","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1182\/blood-2006-04-016725","volume":"108","author":"R Forstpointner","year":"2006","unstructured":"Forstpointner R, Unterhalt M, Dreyling M et al (2006) Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG). Blood 108:4003\u20134008. doi: 10.1182\/blood-2006-04-016725","journal-title":"Blood"},{"key":"1860_CR31","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1200\/JCO.2005.04.164","volume":"23","author":"M Ghielmini","year":"2005","unstructured":"Ghielmini M, Schmitz S-FH, Cogliatti S et al (2005) Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research (SAKK). J Clin Oncol 23:705\u2013711. doi: 10.1200\/JCO.2005.04.164","journal-title":"J Clin Oncol"},{"key":"1860_CR32","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJMoa1200920","volume":"367","author":"HC Kluin-Nelemans","year":"2012","unstructured":"Kluin-Nelemans HC, Hoster E, Hermine O et al (2012) Treatment of older patients with mantle cell lymphoma. N Engl J Med 367:520\u2013531. doi: 10.1056\/NEJMoa1200920","journal-title":"N Engl J Med"},{"key":"1860_CR33","first-page":"152","volume":"120","author":"S Gouill Le","year":"2012","unstructured":"Le Gouill S, Callanan M, Macintyre E et al (2012) Clinical, metabolic and molecular responses after 4 courses of R-DHAP and after autologous stem cell transplantation for untreated mantle cell lymphoma patients included in the LyMa Trial, a Lysa Study. ASH Annu Meet Abstr 120:152","journal-title":"ASH Annu Meet Abstr"},{"key":"1860_CR34","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1200\/JCO.2008.21.3116","volume":"27","author":"NS Andersen","year":"2009","unstructured":"Andersen NS, Pedersen LB, Laurell A et al (2009) Pre-emptive treatment with rituximab of molecular relapse after autologous stem cell transplantation in mantle cell lymphoma. J Clin Oncol 27:4365\u20134370. doi: 10.1200\/JCO.2008.21.3116","journal-title":"J Clin Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-013-1860-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-013-1860-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T01:49:56Z","timestamp":1563673796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-013-1860-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,16]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["1860"],"URL":"https:\/\/doi.org\/10.1007\/s00277-013-1860-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,16]]}}}